Pictet Asset Management’s Abivax ABVX Stock Holding History
Bought
Maintained
Sold
Other funds holding ABVX
NNPTE
NFT
ACL
TCM
ACM
Pictet Asset Management's ABVX Position: Q2 2026 in Review
Pictet Asset Management increased its Abivax (ABVX) stake by 375% in Q2 2026, buying an estimated $44M and bringing the position to 492,068 shares worth $65.6M. The position accounts for 0.06% of the portfolio, ranked #285.
Pictet Asset Management first reported a position in ABVX in Q3 2025 and has held it in 4 quarters since. 105 funds tracked by Wall St. Rank hold ABVX as of Q2 2026.
- Pictet Asset Management held 492,068 shares of Abivax worth $65.6M as of Q2 2026.
- Pictet Asset Management bought 388,523 Abivax shares in Q2 2026, an estimated $44M.
- Abivax made up 0.06% of Pictet Asset Management's portfolio in Q2 2026, its #285 holding.
- Pictet Asset Management first reported a position in Abivax in Q3 2025 and has held it in 4 quarters since.
- 105 funds tracked by Wall St. Rank held Abivax as of Q2 2026.
Based on Pictet Asset Management's 13F filing for Q2 2026, filed 30 Jul 2026.